English name | Budesonide 布地奈德 |
Synonyms | 1,4-PREGNADIEN-(R,S)-11-BETA,16-ALPHA,17,21-TETROL-3,20-DIONECYCLIC16,17ACETAL;BIDIEN;BUDESONIDE;CORTIVENT;EChemicalbookNTOCORTCR;(11-beta,16-alpha)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-dien;16-alpha)-et;PULMICORT |
CAS | 51333-22-3 |
EINECS | 257-139-7 |
Molecular formula | C25H34O6 |
Molecular weight | 430.53 |
Chemical formula |
|
Density | 1.1046 (rough estimate) |
Melting point | 221-232°C (dec.) |
Specific rotation | D25 +98.9° (c = 0.28 in methylene chloride) |
Boiling point | 464.79°C (rough estimate) |
Solubility | Practically insoluble in water, freely soluble in methylene chloride, sparingly soluble in ethanol (96 per cent). |
Solubility of water | 21.53mg/L(temperature not stated) |
Refractive index | 1.4593 (estimate) |
Acidity coefficient | 12.87±0.10(Predicted) |
Storage condition | Store at RT |
Appearance | powder |
Colour | White to Off-White |
Merck | 14,1468 |
BCS class | 2 |
InChIKey | VOVIALXJUBGFJZ-KWVAZRHASA-N |
HS | 29372900 |
Use | For the treatment of skin diseases, asthma and other diseases |
Dangerous mark | toxic substance Xn |
Risk phrases | 40-36/37/38-20/21/22 |
Safety phrases | 22-36-26 |
WGK Germany | 3 |
Hazard Note | LD50 oral in rat: > 3200mg/kg |
RTECS | TU3723000 |
Hazard Class | toxicosis |
Upstream raw materials | N-butyl hydrofluorate |
